greeksoup/ stock research

Intuitive Surgical (ISRG) FY2021 results: revenue $5.7 billion, up 31.0% on the year

Intuitive Surgical Inc. (ISRG) reported revenue of $5.7 billion for fiscal 2021, the year ended 31 December 2021, up 31.0% on the year before. Net income was $1.7 billion, up 60.7%, and diluted earnings per share $4.66. The figures are the company's own, from the 10-K it filed with the SEC on 3 February 2022.

Revenue
$5.7 billion
+31.0% on the year
FY2014FY2021
Operating margin
31.9%
24.1% a year earlier
FY2014FY2021
Net income
$1.7 billion
+60.7% on the year
FY2014FY2021
Diluted EPS
$4.66
+58.5% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue5,7104,3584,478+31.0%
Cost of revenue1,7521,4971,368+17.0%
Gross profit3,9582,8613,110+38.4%
Gross margin69.3%65.6%69.4%
Research and development671595557+12.8%
Selling, general and administrative1,4661,2161,178+20.6%
Operating income1,8211,0501,374+73.5%
Operating margin31.9%24.1%30.7%
Pre-tax income1,8901,2071,502+56.6%
Income tax162140120+15.7%
Effective tax rate8.6%11.6%8.0%
Net income1,7051,0611,379+60.7%
Net margin29.9%24.3%30.8%
Diluted EPS$4.66$2.94$3.85+58.5%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow2,0891,4851,598+40.7%
Capital expenditure340342426-0.6%
Free cash flow1,7501,1431,173+53.1%
Free cash flow margin30.6%26.2%26.2%
Cash from investing-2,462-941-1,154
Cash from financing43.0-85.7-168
Depreciation and amortisation307270200+13.7%
Share-based compensation449395336+13.6%
Buybacks0.0134270
Diluted shares, weighted366m361m358m+1.4%
Shares outstanding at period end358m353m348m+1.3%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity11,9019,7328,264+22.3%
Non-controlling interest50.427.620.9+82.6%
Debt0.00.00.0
Operating lease liabilities66.658.068.7+14.8%
Other liabilities1,5371,3521,380+13.7%
Total liabilities and equity13,55511,1699,733+21.4%
Fixed assets1,8761,5771,273+19.0%
Goodwill344337307+2.0%
Intangible assets70.577.4112-8.9%
Investments7,3295,2464,678+39.7%
Cash and equivalents1,2911,6231,168-20.4%
Receivables783646645+21.3%
Inventory587602596-2.4%
Other assets1,2751,061955+20.1%
Total assets13,55511,1699,733+21.4%

10-K for the year ended 31 December 2021, filed 3 February 2022: the filing.